美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=NEVIRAPINE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE 200244 001 NDA LAMIVUDINE; NEVIRAPINE; STAVUDINE TABLET; ORAL 150MG; 200MG; 30MG No No 2010/09/10 (TA) -- HETERO DRUGS LTD None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE 202171 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET; ORAL 300MG; 300MG; 200MG No No 2011/09/08 (TA) -- MATRIX LABS LTD None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE 202157 001 NDA LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE TABLET; ORAL 150MG; 200MG; 300MG No No 2011/11/18 (TA) -- HETERO LABS UNIT III None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE 202589 001 NDA LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE TABLET; ORAL 150MG; 200MG; 300MG No No 2012/02/08 (TA) -- MACLEODS PHARMS LTD None (Tentative Approval)
NEVIRAPINE 202212 001 NDA NEVIRAPINE TABLET, FOR SUSPENSION; ORAL 50MG No No 2012/04/30 (TA) -- CIPLA LIMITED None (Tentative Approval)
NEVIRAPINE 202212 002 NDA NEVIRAPINE TABLET, FOR SUSPENSION; ORAL 100MG No No 2012/04/30 (TA) -- CIPLA LIMITED None (Tentative Approval)
NEVIRAPINE 077521 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 AUROBINDO Prescription
NEVIRAPINE 077702 001 ANDA NEVIRAPINE SUSPENSION;ORAL 50MG/5ML No No 2012/05/22 2012/05/22 AUROBINDO Prescription
NEVIRAPINE 077956 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 CIPLA Prescription
NEVIRAPINE 078195 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 STRIDES PHARMA Prescription
NEVIRAPINE 078584 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 HETERO LABS LTD III Prescription
NEVIRAPINE 078644 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 PRINSTON INC Discontinued
NEVIRAPINE 078864 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 MYLAN LABS Discontinued
NEVIRAPINE 202523 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 MYLAN PHARMS INC Prescription
NEVIRAPINE 203021 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 APOTEX INC Discontinued
NEVIRAPINE 203080 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 MICRO LABS LTD Prescription
NEVIRAPINE 203176 001 ANDA NEVIRAPINE TABLET;ORAL 200MG No No 2012/05/22 2012/05/22 TECH ORGANIZED Discontinued
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE 202685 001 NDA LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE TABLET, FOR SUSPENSION; ORAL 30MG; 50MG; 60MG No No 2012/09/21 (TA) -- STRIDES ARCOLAB LTD None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE 203076 001 NDA LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE TABLET; ORAL SUSPENSION 30MG; 50MG; 60MG No No 2012/10/16 (TA) -- CIPLA LTD None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE 204505 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET; ORAL 300MG; 300MG; 200MG No No 2013/10/18 (TA) -- AUROBINDO PHARMA LTD None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database